Complexation with C60 Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-20

AUTHORS

Anna Grebinyk, Svitlana Prylutska, Sergii Grebinyk, Yuriy Prylutskyy, Uwe Ritter, Olga Matyshevska, Thomas Dandekar, Marcus Frohme

ABSTRACT

Conventional anticancer chemotherapy is limited because of severe side effects as well as a quickly evolving multidrug resistance of the tumor cells. To address this problem, we have explored a C60 fullerene-based nanosized system as a carrier for anticancer drugs for an optimized drug delivery to leukemic cells.Here, we studied the physicochemical properties and anticancer activity of C60 fullerene noncovalent complexes with the commonly used anticancer drug doxorubicin. C60-Doxorubicin complexes in a ratio 1:1 and 2:1 were characterized with UV/Vis spectrometry, dynamic light scattering, and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The obtained analytical data indicated that the 140-nm complexes were stable and could be used for biological applications. In leukemic cell lines (CCRF-CEM, Jurkat, THP1 and Molt-16), the nanocomplexes revealed ≤ 3.5 higher cytotoxic potential in comparison with the free drug in a range of nanomolar concentrations. Also, the intracellular drug’s level evidenced C60 fullerene considerable nanocarrier function.The results of this study indicated that C60 fullerene-based delivery nanocomplexes had a potential value for optimization of doxorubicin efficiency against leukemic cells. More... »

PAGES

61

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s11671-019-2894-1

DOI

http://dx.doi.org/10.1186/s11671-019-2894-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112260128

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30788638


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/09", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0204", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Condensed Matter Physics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0912", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Materials Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1007", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Nanotechnology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, Am Hubland, 97074, W\u00fcrzburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.8379.5", 
          "name": [
            "Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany", 
            "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine", 
            "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, Am Hubland, 97074, W\u00fcrzburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grebinyk", 
        "givenName": "Anna", 
        "id": "sg:person.012276566530.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012276566530.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prylutska", 
        "givenName": "Svitlana", 
        "id": "sg:person.01265014537.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265014537.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany", 
          "id": "http://www.grid.ac/institutes/grid.438275.f", 
          "name": [
            "Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grebinyk", 
        "givenName": "Sergii", 
        "id": "sg:person.010014412665.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010014412665.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prylutskyy", 
        "givenName": "Yuriy", 
        "id": "sg:person.0761452727.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761452727.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Stra\u00dfe 25 (Curiebau), 98693, Ilmenau, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Stra\u00dfe 25 (Curiebau), 98693, Ilmenau, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ritter", 
        "givenName": "Uwe", 
        "id": "sg:person.0664526675.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664526675.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine", 
          "id": "http://www.grid.ac/institutes/grid.34555.32", 
          "name": [
            "Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matyshevska", 
        "givenName": "Olga", 
        "id": "sg:person.01037270327.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037270327.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, Am Hubland, 97074, W\u00fcrzburg, Germany", 
          "id": "http://www.grid.ac/institutes/grid.8379.5", 
          "name": [
            "Department of Bioinformatics, Biocenter, University of W\u00fcrzburg, Am Hubland, 97074, W\u00fcrzburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dandekar", 
        "givenName": "Thomas", 
        "id": "sg:person.0632077212.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632077212.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany", 
          "id": "http://www.grid.ac/institutes/grid.438275.f", 
          "name": [
            "Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frohme", 
        "givenName": "Marcus", 
        "id": "sg:person.0602127244.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602127244.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11095-014-1566-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035469090", 
          "https://doi.org/10.1007/s11095-014-1566-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/318162a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024648559", 
          "https://doi.org/10.1038/318162a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1986.101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011218841", 
          "https://doi.org/10.1038/bjc.1986.101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/128_2012_414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011013954", 
          "https://doi.org/10.1007/128_2012_414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2402067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014124550", 
          "https://doi.org/10.1038/sj.leu.2402067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s11671-015-1206-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052658781", 
          "https://doi.org/10.1186/s11671-015-1206-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-015-2867-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038060459", 
          "https://doi.org/10.1007/s11051-015-2867-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-20", 
    "datePublishedReg": "2019-02-20", 
    "description": "Conventional anticancer chemotherapy is limited because of severe side effects as well as a quickly evolving multidrug resistance of the tumor cells. To address this problem, we have explored a C60 fullerene-based nanosized system as a carrier for anticancer drugs for an optimized drug delivery to leukemic cells.Here, we studied the physicochemical properties and anticancer activity of C60 fullerene noncovalent complexes with the commonly used anticancer drug doxorubicin. C60-Doxorubicin complexes in a ratio 1:1 and 2:1 were characterized with UV/Vis spectrometry, dynamic light scattering, and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The obtained analytical data indicated that the 140-nm complexes were stable and could be used for biological applications. In leukemic cell lines (CCRF-CEM, Jurkat, THP1 and Molt-16), the nanocomplexes revealed \u2264\u20093.5 higher cytotoxic potential in comparison with the free drug in a range of nanomolar concentrations. Also, the intracellular drug\u2019s level evidenced C60 fullerene considerable nanocarrier function.The results of this study indicated that C60 fullerene-based delivery nanocomplexes had a potential value for optimization of doxorubicin efficiency against leukemic cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s11671-019-2894-1", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7994055", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1037280", 
        "issn": [
          "1931-7573", 
          "1556-276X"
        ], 
        "name": "Nanoscale Research Letters", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "UV/Vis spectrometry", 
      "doxorubicin efficiency", 
      "anticancer drug doxorubicin", 
      "dynamic light scattering", 
      "high-performance liquid chromatography-tandem mass spectrometry", 
      "liquid chromatography-tandem mass spectrometry", 
      "chromatography-tandem mass spectrometry", 
      "noncovalent complexes", 
      "biological applications", 
      "drug doxorubicin", 
      "drug delivery", 
      "physicochemical properties", 
      "mass spectrometry", 
      "light scattering", 
      "conventional anticancer chemotherapy", 
      "nanosized systems", 
      "anticancer activity", 
      "free drug", 
      "high cytotoxic potential", 
      "anticancer drugs", 
      "analytical data", 
      "complexes", 
      "spectrometry", 
      "nanocomplexes", 
      "complexation", 
      "cytotoxic potential", 
      "nanomolar concentrations", 
      "anticancer chemotherapy", 
      "intracellular drug levels", 
      "potential value", 
      "severe side effects", 
      "leukemic cells", 
      "properties", 
      "efficiency", 
      "drugs", 
      "carriers", 
      "doxorubicin", 
      "scattering", 
      "drug levels", 
      "multidrug resistance", 
      "concentration", 
      "potential", 
      "applications", 
      "range", 
      "leukemic cell lines", 
      "cell lines", 
      "side effects", 
      "delivery", 
      "tumor cells", 
      "cells", 
      "activity", 
      "ratio", 
      "resistance", 
      "effect", 
      "values", 
      "chemotherapy", 
      "optimization", 
      "system", 
      "vitro", 
      "comparison", 
      "levels", 
      "results", 
      "study", 
      "lines", 
      "function", 
      "data", 
      "problem"
    ], 
    "name": "Complexation with C60 Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro", 
    "pagination": "61", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112260128"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s11671-019-2894-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30788638"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s11671-019-2894-1", 
      "https://app.dimensions.ai/details/publication/pub.1112260128"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_811.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s11671-019-2894-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s11671-019-2894-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s11671-019-2894-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s11671-019-2894-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s11671-019-2894-1'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      21 PREDICATES      103 URIs      84 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s11671-019-2894-1 schema:about anzsrc-for:02
2 anzsrc-for:0204
3 anzsrc-for:09
4 anzsrc-for:0912
5 anzsrc-for:10
6 anzsrc-for:1007
7 schema:author N6d451fa8799e482f8c049cf14265d989
8 schema:citation sg:pub.10.1007/128_2012_414
9 sg:pub.10.1007/s11051-015-2867-y
10 sg:pub.10.1007/s11095-014-1566-1
11 sg:pub.10.1038/318162a0
12 sg:pub.10.1038/bjc.1986.101
13 sg:pub.10.1038/sj.leu.2402067
14 sg:pub.10.1186/s11671-015-1206-7
15 schema:datePublished 2019-02-20
16 schema:datePublishedReg 2019-02-20
17 schema:description Conventional anticancer chemotherapy is limited because of severe side effects as well as a quickly evolving multidrug resistance of the tumor cells. To address this problem, we have explored a C60 fullerene-based nanosized system as a carrier for anticancer drugs for an optimized drug delivery to leukemic cells.Here, we studied the physicochemical properties and anticancer activity of C60 fullerene noncovalent complexes with the commonly used anticancer drug doxorubicin. C60-Doxorubicin complexes in a ratio 1:1 and 2:1 were characterized with UV/Vis spectrometry, dynamic light scattering, and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The obtained analytical data indicated that the 140-nm complexes were stable and could be used for biological applications. In leukemic cell lines (CCRF-CEM, Jurkat, THP1 and Molt-16), the nanocomplexes revealed ≤ 3.5 higher cytotoxic potential in comparison with the free drug in a range of nanomolar concentrations. Also, the intracellular drug’s level evidenced C60 fullerene considerable nanocarrier function.The results of this study indicated that C60 fullerene-based delivery nanocomplexes had a potential value for optimization of doxorubicin efficiency against leukemic cells.
18 schema:genre article
19 schema:isAccessibleForFree true
20 schema:isPartOf N15eaf5df1c9f4135a426749436c6cace
21 N7ffe960a2f774f9a8cdaef545ae61c12
22 sg:journal.1037280
23 schema:keywords UV/Vis spectrometry
24 activity
25 analytical data
26 anticancer activity
27 anticancer chemotherapy
28 anticancer drug doxorubicin
29 anticancer drugs
30 applications
31 biological applications
32 carriers
33 cell lines
34 cells
35 chemotherapy
36 chromatography-tandem mass spectrometry
37 comparison
38 complexation
39 complexes
40 concentration
41 conventional anticancer chemotherapy
42 cytotoxic potential
43 data
44 delivery
45 doxorubicin
46 doxorubicin efficiency
47 drug delivery
48 drug doxorubicin
49 drug levels
50 drugs
51 dynamic light scattering
52 effect
53 efficiency
54 free drug
55 function
56 high cytotoxic potential
57 high-performance liquid chromatography-tandem mass spectrometry
58 intracellular drug levels
59 leukemic cell lines
60 leukemic cells
61 levels
62 light scattering
63 lines
64 liquid chromatography-tandem mass spectrometry
65 mass spectrometry
66 multidrug resistance
67 nanocomplexes
68 nanomolar concentrations
69 nanosized systems
70 noncovalent complexes
71 optimization
72 physicochemical properties
73 potential
74 potential value
75 problem
76 properties
77 range
78 ratio
79 resistance
80 results
81 scattering
82 severe side effects
83 side effects
84 spectrometry
85 study
86 system
87 tumor cells
88 values
89 vitro
90 schema:name Complexation with C60 Fullerene Increases Doxorubicin Efficiency against Leukemic Cells In Vitro
91 schema:pagination 61
92 schema:productId N084700713fbd4e4ba11a1019852ff2c7
93 N53a3ab29098246ad99260478b688f5ad
94 Nd9e2eefbc150413b81340eae057483b3
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112260128
96 https://doi.org/10.1186/s11671-019-2894-1
97 schema:sdDatePublished 2022-10-01T06:45
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher Nad833f5530e74a0ba8f292baaf70fc22
100 schema:url https://doi.org/10.1186/s11671-019-2894-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N030609f3e98c4fdf888b83ef081039f2 rdf:first sg:person.0761452727.99
105 rdf:rest Nbd137ad2c2274b6bacc40e286dc45c90
106 N04d7821ad0b941d69392c0369f171ddb rdf:first sg:person.01265014537.58
107 rdf:rest Nfde9aecf7a8e44d7b31111ceecf3bb72
108 N084700713fbd4e4ba11a1019852ff2c7 schema:name dimensions_id
109 schema:value pub.1112260128
110 rdf:type schema:PropertyValue
111 N15eaf5df1c9f4135a426749436c6cace schema:issueNumber 1
112 rdf:type schema:PublicationIssue
113 N53a3ab29098246ad99260478b688f5ad schema:name pubmed_id
114 schema:value 30788638
115 rdf:type schema:PropertyValue
116 N6d451fa8799e482f8c049cf14265d989 rdf:first sg:person.012276566530.16
117 rdf:rest N04d7821ad0b941d69392c0369f171ddb
118 N7ffe960a2f774f9a8cdaef545ae61c12 schema:volumeNumber 14
119 rdf:type schema:PublicationVolume
120 N80aa2437c9324deeb1ce2dcd9f23beef rdf:first sg:person.01037270327.44
121 rdf:rest N95a8871f14fe40569547afb1900bacf4
122 N95a8871f14fe40569547afb1900bacf4 rdf:first sg:person.0632077212.29
123 rdf:rest Ne60c9b50cb26438480b47fdac7967a0f
124 Nad833f5530e74a0ba8f292baaf70fc22 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 Nbd137ad2c2274b6bacc40e286dc45c90 rdf:first sg:person.0664526675.56
127 rdf:rest N80aa2437c9324deeb1ce2dcd9f23beef
128 Nd9e2eefbc150413b81340eae057483b3 schema:name doi
129 schema:value 10.1186/s11671-019-2894-1
130 rdf:type schema:PropertyValue
131 Ne60c9b50cb26438480b47fdac7967a0f rdf:first sg:person.0602127244.54
132 rdf:rest rdf:nil
133 Nfde9aecf7a8e44d7b31111ceecf3bb72 rdf:first sg:person.010014412665.93
134 rdf:rest N030609f3e98c4fdf888b83ef081039f2
135 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
136 schema:name Physical Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:0204 schema:inDefinedTermSet anzsrc-for:
139 schema:name Condensed Matter Physics
140 rdf:type schema:DefinedTerm
141 anzsrc-for:09 schema:inDefinedTermSet anzsrc-for:
142 schema:name Engineering
143 rdf:type schema:DefinedTerm
144 anzsrc-for:0912 schema:inDefinedTermSet anzsrc-for:
145 schema:name Materials Engineering
146 rdf:type schema:DefinedTerm
147 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
148 schema:name Technology
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1007 schema:inDefinedTermSet anzsrc-for:
151 schema:name Nanotechnology
152 rdf:type schema:DefinedTerm
153 sg:grant.7994055 http://pending.schema.org/fundedItem sg:pub.10.1186/s11671-019-2894-1
154 rdf:type schema:MonetaryGrant
155 sg:journal.1037280 schema:issn 1556-276X
156 1931-7573
157 schema:name Nanoscale Research Letters
158 schema:publisher Springer Nature
159 rdf:type schema:Periodical
160 sg:person.010014412665.93 schema:affiliation grid-institutes:grid.438275.f
161 schema:familyName Grebinyk
162 schema:givenName Sergii
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010014412665.93
164 rdf:type schema:Person
165 sg:person.01037270327.44 schema:affiliation grid-institutes:grid.34555.32
166 schema:familyName Matyshevska
167 schema:givenName Olga
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037270327.44
169 rdf:type schema:Person
170 sg:person.012276566530.16 schema:affiliation grid-institutes:grid.8379.5
171 schema:familyName Grebinyk
172 schema:givenName Anna
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012276566530.16
174 rdf:type schema:Person
175 sg:person.01265014537.58 schema:affiliation grid-institutes:grid.34555.32
176 schema:familyName Prylutska
177 schema:givenName Svitlana
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265014537.58
179 rdf:type schema:Person
180 sg:person.0602127244.54 schema:affiliation grid-institutes:grid.438275.f
181 schema:familyName Frohme
182 schema:givenName Marcus
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602127244.54
184 rdf:type schema:Person
185 sg:person.0632077212.29 schema:affiliation grid-institutes:grid.8379.5
186 schema:familyName Dandekar
187 schema:givenName Thomas
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632077212.29
189 rdf:type schema:Person
190 sg:person.0664526675.56 schema:affiliation grid-institutes:None
191 schema:familyName Ritter
192 schema:givenName Uwe
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664526675.56
194 rdf:type schema:Person
195 sg:person.0761452727.99 schema:affiliation grid-institutes:grid.34555.32
196 schema:familyName Prylutskyy
197 schema:givenName Yuriy
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761452727.99
199 rdf:type schema:Person
200 sg:pub.10.1007/128_2012_414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011013954
201 https://doi.org/10.1007/128_2012_414
202 rdf:type schema:CreativeWork
203 sg:pub.10.1007/s11051-015-2867-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1038060459
204 https://doi.org/10.1007/s11051-015-2867-y
205 rdf:type schema:CreativeWork
206 sg:pub.10.1007/s11095-014-1566-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035469090
207 https://doi.org/10.1007/s11095-014-1566-1
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/318162a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024648559
210 https://doi.org/10.1038/318162a0
211 rdf:type schema:CreativeWork
212 sg:pub.10.1038/bjc.1986.101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011218841
213 https://doi.org/10.1038/bjc.1986.101
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/sj.leu.2402067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014124550
216 https://doi.org/10.1038/sj.leu.2402067
217 rdf:type schema:CreativeWork
218 sg:pub.10.1186/s11671-015-1206-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052658781
219 https://doi.org/10.1186/s11671-015-1206-7
220 rdf:type schema:CreativeWork
221 grid-institutes:None schema:alternateName Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693, Ilmenau, Germany
222 schema:name Institute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693, Ilmenau, Germany
223 rdf:type schema:Organization
224 grid-institutes:grid.34555.32 schema:alternateName Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine
225 schema:name Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine
226 rdf:type schema:Organization
227 grid-institutes:grid.438275.f schema:alternateName Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany
228 schema:name Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany
229 rdf:type schema:Organization
230 grid-institutes:grid.8379.5 schema:alternateName Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074, Würzburg, Germany
231 schema:name Department of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074, Würzburg, Germany
232 Division Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745, Wildau, Germany
233 Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine
234 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...